Evoke plc (LON:EVOK – Get Free Report)’s share price fell 10% on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analysts Forecast Growth
EVOK has been the topic of several research reports. Berenberg Bank cut their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group reissued a “buy” rating and set a GBX 140 ($1.81) price target on shares of Evoke in a research report on Monday, December 16th.
Get Our Latest Analysis on EVOK
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. Sell-side analysts expect that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Buying and Selling at Evoke
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was bought at an average cost of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by corporate insiders.
About Evoke
Further Reading
- Five stocks we like better than Evoke
- Should You Invest in Penny Stocks?
- MarketBeat Week in Review – 03/24 – 03/28
- The 3 Best Fintech Stocks to Buy Now
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.